By proceeding, you agree to our Terms of Use and Privacy Policy.
Welcome to the 4th Chronic Kidney Disease Drug Development Summit (CKD3) The 4th Chronic Kidney Disease Drug Development Summit (CKD3) is the definitive industry forum dedicated to presenting actionable insights into how the latest scientific research is being applied to pipeline progress in chronic kidney disease.
Speakers sessions on molecular phenotyping of disease etiology and drug development for kidney disease will help you focus on preventative therapies.
As experts from Novartis and J&J shed light on how to cure kidney diseases with preventative therapies, you will be able to enhance patient satisfaction.
Overcome hindrances in the way of your research for developing ideal therapies for kidney diseases by networking with experts from therapeutics.
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
Visualizing the Future – Minimizing risk Antaros Medical is an entirely unique service provider. We are pioneering new frontiers in innovative MRI/PET imaging techniques, seamless clinical drug development and understanding of human pathophysiology.
Founded in 2008, we are a privately-held biotech company with two primary areas of business: Pre-clinical contract research (CRO) services and proprietary early target and drug discovery programs.
Best in class in vitro models to accurately predict in vivo outcomes.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.